Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Methods ; 16(27): 4431-4484, 2024 Jul 11.
Article in English | MEDLINE | ID: mdl-38913433

ABSTRACT

Since the aggregation-based emission (AIE) phenomenon emerged in 2001, numerous chemical designs have been built around the AIE concept, displaying its utility for diverse applications, including optics, electronics, energy, and biosciences. The present review critically evaluates the broad applicability of AIEgen-based chemical models towards sensing small analytes and the structural design strategies adjusting the mode of action reported since the last decade. Various AIEgen models have been discussed, providing qualitative and quantitative estimation of cationic metal ions and anionic species, as well as biomolecular, cellular, and organelle-specific probes. A systematic overview of the reported structural design and the underlying working mode will pave the way for designing and developing the next generation of AIEgens for specific applications.

2.
Anal Methods ; 16(15): 2198-2228, 2024 Apr 18.
Article in English | MEDLINE | ID: mdl-38567418

ABSTRACT

The CN bond isomerization/modulation as a fluorescence signalling mechanism was explored by studying the photophysical properties of conformationally restricted molecules. From the beginning, the CN bond isomerization method has attracted the attention of researchers owing to its simplicity, high selectivity, and sensitivity in fluorescence evaluation. Continuous developments in the field of sensing using CN bond-containing compounds have been achieved via the customization of the isomerization process around the CN bond in numerous ways, and the results were obtained in the form of specific discrete photophysical changes. CN isomerization causes significant fluorescence enhancement in response to detected metal cations and other reactive species (Cys, Hys, ClO-, etc.) straightforwardly and effectively. This review sheds light on the process of CN bond isomerization/modulation as a signalling mechanism depending on fluorescence changes via conformational restriction. In addition, CN bond isomerization-based fluorescent sensors have yet to be well reviewed, although several fluorescent sensors based on this signalling mechanism have been reported. Therefore, CN-based fluorescent sensors are summarized in this review.

3.
Clin Endosc ; 53(4): 436-442, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32252499

ABSTRACT

BACKGROUND/AIMS: This study aimed to study the endoscopic yield, appropriateness, and complications of pediatric endoscopy performed by adult gastroenterologists in an adult endoscopic suite. METHODS: This a retrospective study in which records of all the patients less than 18 years of age who underwent endoscopy in the last 5 years were studied. The indications of endoscopy in children were categorized as appropriate or inappropriate per the latest guidelines by American Society for Gastrointestinal Endoscopy and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Positive endoscopic yield was defined as the presence of any abnormality on endoscopy. RESULTS: Among the total of 822 children (age <18 years), the most common indications were variceal surveillance/eradication in 157 (19.1%), followed by dyspepsia in 143 (17.4%), upper gastrointestinal (UGI) bleeding in 136 (16.5%), recurrent abdominal pain in 94 (11.4%), unexplained anemia in 74 (9%), recurrent vomiting in 50 (6.08%), chronic refractory gastroesophageal reflux disease in 34 (4.1%) and others; 780 out of 822 endoscopic procedures (94.9%) done in children were appropriate as per the guidelines. The endoscopic yield was 45.8%, highest in patients with UGI bleeding (71.3%), followed by variceal surveillance (54.8%), recurrent vomiting (38%), dyspepsia (37.8%), and recurrent abdominal pain (36%). Minor adverse events occurred in 7.3% of children. CONCLUSION: Pediatric endoscopy performed by an experienced adult gastroenterologist may be acceptable if done in cooperation with a pediatrician.

4.
J Fluoresc ; 27(6): 2279-2286, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28840438

ABSTRACT

We report a structure of ferrocene-pyrene conjugate (1) comprising electro and photo-active dual-signaling units. In particular, 1 upon interaction with Cu(II), displays selectively one-photon fluorescence quenching, but it shows two-photon absorption (TPA) cross-section 1230 GM (at 780 nm). Further, 1 displayed two irreversible oxidative waves at 0.39 V and 0.80 V (vs Ag/AgCl), in the electrochemical analysis which upon addition of Cu2+, led to the negative potential shift in both the oxidative waves to appear at 0.25 V and 0.68 V. The triple mode changes in presence of Cu(II) suggesting the possible application of 1 for the detection of Cu(II) in aqueous media. Graphical Abstract.

5.
Indian J Gastroenterol ; 34(5): 372-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26531066

ABSTRACT

BACKGROUND: Hepatitis B virus (HBV) infection in cancer patients receiving chemotherapy carries high morbidity and mortality. Conventional hepatitis B vaccination with three doses at 0, 1, and 6 months apart is ineffective in prevention of HBV infection. OBJECTIVES: To compare the efficacy of accelerated, multiple, double-dose HB vaccine with conventional HB vaccine in cancer patients receiving chemotherapy (CT). METHODS: Patients of cancer who were planned for CT were screened for HBV markers (HBsAg, total anti-HB core, anti-HBs antibody and HBV DNA). Patients with negative HBV serum markers received HB vaccine in two groups. Group A received three double doses (40 µg) of recombinant HB vaccine at 0, 1, and 3 weeks before CT and additional three double doses post CT. Group B received HB vaccine (20 µg) at 0, 1, and 6 months. Efficacy of vaccine in the two groups was compared by anti-HBs titers achieved at 3, 6, and 9 months and by HBsAg positivity following CT at 1 year follow up. RESULTS: Protective anti-HBs titers (>10 mIU/mL) at 3, 6, and 9 months in group A and B was 41.1 %, 66.2 %, and 76% and 26 %, 37.7 %, and 49% respectively (p = 0.001). Seven of 454 (1.5%) patients in group A became HBsAg positive after vaccination compared to 19/472 (4.0%) in group B (p = 0.022). CONCLUSION: Accelerated, multiple, double-dose HB vaccine increases seroprotection and is more effective than conventional HB vaccine in preventing HBV infection.


Subject(s)
Antineoplastic Agents/therapeutic use , Hepatitis B Vaccines/administration & dosage , Hepatitis B/prevention & control , Neoplasms/drug therapy , Adolescent , Adult , Aged , Biomarkers/blood , Child , Child, Preschool , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Hepatitis B/diagnosis , Hepatitis B Antibodies/blood , Humans , Infant , Male , Middle Aged , Prospective Studies , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...